PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-10 1:14 pm Purchase |
2020-11-30 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
PRICE T ROWE ASSOCIATES INC | 3,639,190 2.800% |
2,124 (+0.06%) |
Filing |
| 2020-11-10 3:09 pm Purchase |
2020-10-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
PRICE T ROWE ASSOCIATES INC | 3,637,066 18.700% |
3,637,066 (New Position) |
Filing |